Table 4. PCR performance for fetal Toxoplasmosis diagnosis for all the trimesters and each trimester of pregnancy.
| Group/statistics | Model | Estimate | CIinf | CIsup | I2 | CIinf | CIsup |
|---|---|---|---|---|---|---|---|
| All studies(n = 24) | - | - | - | - | - | - | - |
| Se | Bivariate | 0.83 | 0.771 | 0.877 | 0.665 | 0.486 | 0.782 |
| Sp | Bivariate | 0.983 | 0.969 | 0.991 | 0.688 | 0.525 | 0.795 |
| DOR | D&L | 453.482 | 182.933 | 1124.155 | 0.484 | 0.171 | 0.679 |
| Correlation | - | -0.054 | -0.447 | 0.357 | - | - | - |
| 1° Tri(n = 6) | - | - | - | - | - | - | - |
| Se | Bivariate | 0.569 | 0.395 | 0.727 | 0 | 0 | 0.659 |
| Sp | Bivariate | 0.992 | 0.982 | 0.997 | 0 | 0 | 0 |
| DOR | D&L | 305.289 | 66.95 | 1392.102 | 0 | 0 | 0.214 |
| Correlation | - | 0.589 | -0.426 | 0.948 | - | - | - |
| 2° Tri(n = 10) | - | - | - | - | - | - | - |
| Se | Bivariate | 0.879 | 0.782 | 0.936 | 0.698 | 0.419 | 0.843 |
| Sp | Bivariate | 0.964 | 0.938 | 0.98 | 0.191 | 0 | 0.598 |
| DOR | D&L | 269.219 | 107.73 | 672.781 | 0.139 | 0 | 0.551 |
| Correlation | - | -0.43 | -0.834 | 0.273 | - | - | - |
| 3° Tri(n = 6) | - | - | - | - | - | - | - |
| Se | Bivariate | 0.756 | 0.66 | 0.831 | 0 | 0 | 0.717 |
| Sp | Bivariate | 0.912 | 0.802 | 0.963 | 0 | 0 | 0.156 |
| DOR | D&L | 55.552 | 9.89 | 312.037 | 0 | 0 | 0.727 |
| Correlation | - | -0.173 | -0.863 | 0.743 | - | - | - |
CIinf, 95% confidence interval inferior limit; CIsup, 95% confidence interval superior limit; DOR, diagnostic odds ratio; I2, heterogeneity statistic; n, number of studies, Se, sensitivity, Sp, specificity